Place · Level 3 · Condition
GERD
TLESR + 食管裂孔疝 · PPI 双刃剑 · 生活方式 5 件套 · Barrett 监测 · 鉴别心绞痛 / LPR · 孕期 + 夜间专项
Story path
Chapter 1
GERD · mechanism
GERD · mechanism
Gastroesophageal reflux disease (GERD) = gastric contents refluxing into the esophagus producing symptoms or complications, persisting ≥ several episodes/week.
Epidemiology:
Chinese adults ~ 5-10% weekly symptoms (Wang 2010 China survey)Western 20-25%Typical presentation: heartburn + acid regurgitation + retrosternal burningAtypical: chronic cough / asthma / laryngitis / dental erosion / recurrent otitis media (children)"Nocturnal heartburn waking" = red flag
Mechanism · the pressure-gradient + one-way-valve story:
Reflux is fundamentally a pressure-difference problem. Between the esophagus (intrathoracic, slightly negative) and the stomach (intra-abdominal, positive), the lower esophageal sphincter (LES) acts as a one-way valve. When the valve seals tightly, gastric contents stay put; when it briefly opens and abdominal pressure pushes, reflux happens.
Crucially, the valve opens dozens of times every day on its own — this is the Transient LES Relaxation (TLESR), a physiologic event that lets swallowed air burp out. GERD is not a broken valve — it is the combination of TLESR being too frequent + each opening lasting too long + refluxate present at the moment. So healthy people getting occasional heartburn and GERD patients differ in degree, not in kind.
This frame explains the four main aggravating pathways — each is a sub-mechanism that makes the one-way valve easier to breach:
The LES itself is weak: low resting pressure (scleroderma, certain drugs, tobacco, alcohol, high-fat meals) → baseline seal degradedHiatal hernia: part of the stomach herniates into the thorax, so the LES loses the crural-diaphragm support → TLESR frequency and reflux probability both riseDelayed gastric emptying: diabetic gastroparesis / large meals / high-fat content → sustained intragastric pressure → more pushRaised abdominal pressure: obesity / pregnancy / tight clothing / bending right after meals → adds force from below
Why supine + nighttime is worst: when you stand, gravity helps push reflux back down; lying flat removes that, and swallowing (the main mechanism for clearing the esophagus) almost stops during sleep. So the rule of *no food in the 3 h before bed + raise the head of the bed 15 cm* is physics, not folklore.
Triggers / aggravators:
Food: high-fat + chocolate + mint + coffee + tea + alcohol + soft drinks + chili + tomato + citrus + garlic + onionBehavior: lying down right after meals + large meals + late-night eating + tight clothing + bending overDrugs: NSAIDs + calcium-channel blockers + nitroglycerin + theophylline + anticholinergics + bisphosphonates + antidepressantsSmoking + alcohol + obesity
Diagnosis:
Typical symptoms + positive PPI trial (4-8 weeks) = clinical diagnosis; endoscopy not required for everyoneEndoscopy: required for red flags (50+ y/o new onset / dysphagia / weight loss / anemia / melena / persistent vomiting)24-h pH-impedance / esophageal manometry: for refractory or atypical casesBravo capsule: extended pH monitoring
Complications:
Esophagitis (LA-A to LA-D) + ulcers + stricturesBarrett's esophagus (BE): distal-esophageal metaplasia → adenocarcinoma precursor (0.1-0.3%/year progression, see Barrett scene)Esophageal adenocarcinoma: one of the fastest-rising cancers in the West over the past 30 yearsAsthma / COPD worsening (microaspiration)Dental erosion
Epidemiology:
Chinese adults ~ 5-10% weekly symptoms (Wang 2010 China survey)Western 20-25%Typical presentation: heartburn + acid regurgitation + retrosternal burningAtypical: chronic cough / asthma / laryngitis / dental erosion / recurrent otitis media (children)"Nocturnal heartburn waking" = red flag
Mechanism · the pressure-gradient + one-way-valve story:
Reflux is fundamentally a pressure-difference problem. Between the esophagus (intrathoracic, slightly negative) and the stomach (intra-abdominal, positive), the lower esophageal sphincter (LES) acts as a one-way valve. When the valve seals tightly, gastric contents stay put; when it briefly opens and abdominal pressure pushes, reflux happens.
Crucially, the valve opens dozens of times every day on its own — this is the Transient LES Relaxation (TLESR), a physiologic event that lets swallowed air burp out. GERD is not a broken valve — it is the combination of TLESR being too frequent + each opening lasting too long + refluxate present at the moment. So healthy people getting occasional heartburn and GERD patients differ in degree, not in kind.
This frame explains the four main aggravating pathways — each is a sub-mechanism that makes the one-way valve easier to breach:
The LES itself is weak: low resting pressure (scleroderma, certain drugs, tobacco, alcohol, high-fat meals) → baseline seal degradedHiatal hernia: part of the stomach herniates into the thorax, so the LES loses the crural-diaphragm support → TLESR frequency and reflux probability both riseDelayed gastric emptying: diabetic gastroparesis / large meals / high-fat content → sustained intragastric pressure → more pushRaised abdominal pressure: obesity / pregnancy / tight clothing / bending right after meals → adds force from below
Why supine + nighttime is worst: when you stand, gravity helps push reflux back down; lying flat removes that, and swallowing (the main mechanism for clearing the esophagus) almost stops during sleep. So the rule of *no food in the 3 h before bed + raise the head of the bed 15 cm* is physics, not folklore.
Triggers / aggravators:
Food: high-fat + chocolate + mint + coffee + tea + alcohol + soft drinks + chili + tomato + citrus + garlic + onionBehavior: lying down right after meals + large meals + late-night eating + tight clothing + bending overDrugs: NSAIDs + calcium-channel blockers + nitroglycerin + theophylline + anticholinergics + bisphosphonates + antidepressantsSmoking + alcohol + obesity
Diagnosis:
Typical symptoms + positive PPI trial (4-8 weeks) = clinical diagnosis; endoscopy not required for everyoneEndoscopy: required for red flags (50+ y/o new onset / dysphagia / weight loss / anemia / melena / persistent vomiting)24-h pH-impedance / esophageal manometry: for refractory or atypical casesBravo capsule: extended pH monitoring
Complications:
Esophagitis (LA-A to LA-D) + ulcers + stricturesBarrett's esophagus (BE): distal-esophageal metaplasia → adenocarcinoma precursor (0.1-0.3%/year progression, see Barrett scene)Esophageal adenocarcinoma: one of the fastest-rising cancers in the West over the past 30 yearsAsthma / COPD worsening (microaspiration)Dental erosion
GERD vs LPR · silent symptoms
Reflux ≠ always heartburn — roughly 30-50% of reflux is "silent GERD", presenting with extra-esophageal symptoms and routinely misdiagnosed by ENT / pulmonology / cardiology.LPR (Laryngopharyngeal Reflux):
Reflux reaches the larynx / vocal cords rather than primarily the esophagusSymptoms: chronic cough + throat clearing + hoarseness + globus + postnasal drip + recurrent vocal-cord granulomasKey: LPR patients often have no typical heartburn → misdiagnosed as "chronic pharyngitis" / "allergic rhinitis" for yearsDiagnosis: indirect laryngoscopy + RSI (Reflux Symptom Index) ≥ 13 + empirical PPI 8-12 weeks (longer trial than GERD)
Hidden clinical manifestations of silent GERD:
Chronic nocturnal cough (cough variant) — 30% of chronic cough cases are actually GERDWorsening / refractory asthma — comorbidity rate 50-60%, PPI trial may reduce med burdenRecurrent otitis / sinusitis (children) — microaspiration into the Eustachian tubeDental erosion + recurrent caries — often first noticed by the dentistChronic sinus congestionUnexplained chest pain (non-anginal) — see differential sceneDysphagia / food impaction — red flag, mandates endoscopy
Differential pointers (clinical):
Typical GERD: heartburn + acid regurgitation → 4-week PPI trialSuspected LPR: throat symptoms without heartburn → laryngoscopy + 8-12 weeks PPI + head-of-bed elevation + strict dietChronic cough (no asthma + non-smoker): "3 main causes" = GERD / cough-variant asthma / upper-airway cough syndrome → sequential trialsRecurrent pediatric otitis / cough: do not forget reflux
Why silent GERD is hard to diagnose:
Non-specific symptoms, overlap with allergy / infection / psychological24-h pH monitoring has low sensitivity in LPR (~ 30-50% false-negative)PPI trial works more slowly in LPR (8-12 weeks vs 4 weeks for GERD) — easy to abandon prematurelyMost clinicians do not place GERD at the top of the "chronic cough / throat" differential
Practice:
Chronic cough ≥ 8 weeks + ruled out asthma + ruled out upper airway → try PPI 8-12 weeks + head-of-bed elevation + avoid triggersRecurrent hoarseness + globus → laryngoscopy + sameDo not exclude GERD just because "there is no heartburn"
Chapter 2
PPI long-term · double-edged
PPI long-term · double-edged
Proton pump inhibitors (PPIs) — the revolutionary 1980s drug class:
Mechanism:
Irreversibly inhibit the gastric parietal-cell proton pump (H+/K+ ATPase) → gastric acid secretion ↓ 99%Omeprazole / lansoprazole / pantoprazole / rabeprazole / esomeprazole / dexlansoprazole
Effective indications:
GERD esophagitisPeptic ulcer disease (PUD)H. pylori eradication (PPI + antibiotics)NSAID-associated ulcer prevention (high-risk patients)Zollinger-Ellison syndromeBarrett's esophagus (in the context of cancer surveillance)
PPI overuse problem:
40-70% of prescriptions lack a clear indication (US / China data are similar)"Any stomach discomfort → PPI" is widespreadPPI rebound dependency: abrupt cessation → acid rebound → symptoms worsen → restart → use lengthens indefinitely
Long-term PPI (> 1 year) risks (also covered by the atlas report rules):
B12 deficiency: lack of acid → protein-bound B12 cannot be released → see atlas vitamin-b12/stomach L4↓ Ca absorption → hip-fracture risk ↑ (FDA 2010 warning)Mg deficiency (FDA 2011 warning): low Mg → arrhythmia / cramping↓ Fe absorption → iron-deficiency anemia↑ C. difficile infection (loss of acid barrier)↑ Community-acquired pneumonia (CAP)CKD risk (Lam 2017 et al.)Dementia / cardiovascular associations: data mixed, causality unestablished
Proper PPI use:
Clear indication + lowest effective dose + shortest durationDeprescribing strategy: gradual taper (2-4 weeks, not abrupt) + H2-blocker bridge (famotidine)Patients who need PPI but worry about side effects: discuss intermittent use (on-demand / pulse / every-other-day) with the doctorDo not stop on your own: Barrett's / severe esophagitis / previous bleeding ulcer need long-term PPI
H2-receptor antagonist (H2RA) alternative:
Famotidine / ranitidine (withdrawn — NDMA contamination) / cimetidineGentler, fewer side effects, but ~ 70% the potency of PPIsSuited to mild-to-moderate GERD + PPI taper / dose reduction
Antacids:
Tums (CaCO₃) + Maalox (Al/Mg) + Gaviscon (alginate)On-demand only, not long-termAlginate forms a raft over gastric contents → physically blocks reflux
P-CAB (potassium-competitive acid blocker) new generation:
Vonoprazan: launched in China 2022Faster onset + longer maintenance + similar efficacy vs PPIsLong-term side-effect data still accumulating
Mechanism:
Irreversibly inhibit the gastric parietal-cell proton pump (H+/K+ ATPase) → gastric acid secretion ↓ 99%Omeprazole / lansoprazole / pantoprazole / rabeprazole / esomeprazole / dexlansoprazole
Effective indications:
GERD esophagitisPeptic ulcer disease (PUD)H. pylori eradication (PPI + antibiotics)NSAID-associated ulcer prevention (high-risk patients)Zollinger-Ellison syndromeBarrett's esophagus (in the context of cancer surveillance)
PPI overuse problem:
40-70% of prescriptions lack a clear indication (US / China data are similar)"Any stomach discomfort → PPI" is widespreadPPI rebound dependency: abrupt cessation → acid rebound → symptoms worsen → restart → use lengthens indefinitely
Long-term PPI (> 1 year) risks (also covered by the atlas report rules):
B12 deficiency: lack of acid → protein-bound B12 cannot be released → see atlas vitamin-b12/stomach L4↓ Ca absorption → hip-fracture risk ↑ (FDA 2010 warning)Mg deficiency (FDA 2011 warning): low Mg → arrhythmia / cramping↓ Fe absorption → iron-deficiency anemia↑ C. difficile infection (loss of acid barrier)↑ Community-acquired pneumonia (CAP)CKD risk (Lam 2017 et al.)Dementia / cardiovascular associations: data mixed, causality unestablished
Proper PPI use:
Clear indication + lowest effective dose + shortest durationDeprescribing strategy: gradual taper (2-4 weeks, not abrupt) + H2-blocker bridge (famotidine)Patients who need PPI but worry about side effects: discuss intermittent use (on-demand / pulse / every-other-day) with the doctorDo not stop on your own: Barrett's / severe esophagitis / previous bleeding ulcer need long-term PPI
H2-receptor antagonist (H2RA) alternative:
Famotidine / ranitidine (withdrawn — NDMA contamination) / cimetidineGentler, fewer side effects, but ~ 70% the potency of PPIsSuited to mild-to-moderate GERD + PPI taper / dose reduction
Antacids:
Tums (CaCO₃) + Maalox (Al/Mg) + Gaviscon (alginate)On-demand only, not long-termAlginate forms a raft over gastric contents → physically blocks reflux
P-CAB (potassium-competitive acid blocker) new generation:
Vonoprazan: launched in China 2022Faster onset + longer maintenance + similar efficacy vs PPIsLong-term side-effect data still accumulating
PPI deprescribing + P-CAB
Discontinuing PPIs is something medical training rarely teaches — most clinicians know how to start them but not how to stop. Yet after 8+ weeks of use, abrupt cessation produces "acid rebound" in 50-70% of patients, turning PPIs into an effective "dependency."Why rebound happens (Rebound Acid Hypersecretion, RAH):
Long-term PPI → ↓ acid → parietal-cell compensatory hyperplasia + ↑ gastrin (feedback)Abrupt stop → hyperplastic cells reactivate + high gastrin still drives them → acid transiently above pre-PPI baselinePatient feels "worse than when I started" → mistakenly concludes "I must take PPI" → restarts, permanently dependentHealthy subjects in the Reimer 2009 Gastroenterology RCT: 8 weeks of PPI followed by abrupt stop → 44% developed new reflux symptoms
Tapering strategy (recommended path):
Weeks 1-2: halve the current dose (e.g., 20 mg → 10 mg, or every other day)
Weeks 3-4: further reduction (10 mg → every-other-day 10 mg)
Weeks 5-6: stop PPI completely, bridge with famotidine 20 mg at bedtime
Weeks 7-8: H2RA on-demand only → fully off
Throughout: strict lifestyle (head-of-bed elevation + avoid triggers + weight loss)
Rebound toolkit:
Alginate (Gaviscon / Algicon) on demand — does not affect acid, forms a physical raft barrierFamotidine 20-40 mg at bedtime — suppresses acid but does not cause reboundMagnesium hydroxide / calcium carbonate antacids on demand — immediate reliefDo not go back to PPI unless there is a clear indication
Vonoprazan · the new P-CAB generation:
Launched in China 2022, FDA-approved for erosive esophagitis 2024Mechanism: potassium-competitive H+/K+ ATPase inhibition, reversible + does not require acid activation (PPIs do)Advantages vs PPI (Laine 2023 Gastroenterology RCT, n=1024):Severe esophagitis (LA C/D) healing rate 80% vs lansoprazole 64%Faster onset (1 day vs 3-5)No pre-meal dosing neededLonger half-life (~ 9 h) → better nocturnal reflux controlConcerns: long-term (> 2 years) data still accumulating; more marked gastrin elevation → theoretical ECL-cell hyperplasia / carcinoid risk (rodent data, no confirmed human signal)Suited to: PPI-refractory GERD + severe esophagitis + H. pylori eradication
P-CAB vs PPI choice:
PPI remains first-line for most GERD (cheap + long-term data + usually sufficient)PPI 8 weeks but still severe symptoms / severe esophagitis / hard-to-control nocturnal reflux: upgrade to P-CABDo not default to P-CAB as a "premium PPI": long-term data + price + regional access differences
Chapter 3
Barrett + chest pain differential
Barrett + chest pain differential
Two things not to miss: (1) cancer surveillance in Barrett's esophagus, (2) differentiating reflux chest pain from angina.
Barrett's esophagus (BE) — the "precancerous" metaplasia of long-standing GERD:
Pathology: distal esophageal squamous epithelium → columnar + goblet cells (intestinal metaplasia)Mechanism: repeated acid + bile insult → protective metaplastic remodeling — but this metaplasia has malignant potentialEpidemiology: 5-15% of long-standing GERD patients develop BE; Chinese GERD patients have a lower BE rate (~ 1-2%) than Western populationsProgression: BE → low-grade dysplasia (LGD) ~ 0.7%/year → high-grade dysplasia (HGD) ~ 0.5%/year → esophageal adenocarcinoma ~ 0.1-0.3%/year (non-dysplastic BE)Esophageal adenocarcinoma (EAC): one of the fastest-rising cancers in the West over the past 40 years (paralleling obesity + GERD)
Barrett's esophagus (BE) — the "precancerous" metaplasia of long-standing GERD:
Pathology: distal esophageal squamous epithelium → columnar + goblet cells (intestinal metaplasia)Mechanism: repeated acid + bile insult → protective metaplastic remodeling — but this metaplasia has malignant potentialEpidemiology: 5-15% of long-standing GERD patients develop BE; Chinese GERD patients have a lower BE rate (~ 1-2%) than Western populationsProgression: BE → low-grade dysplasia (LGD) ~ 0.7%/year → high-grade dysplasia (HGD) ~ 0.5%/year → esophageal adenocarcinoma ~ 0.1-0.3%/year (non-dysplastic BE)Esophageal adenocarcinoma (EAC): one of the fastest-rising cancers in the West over the past 40 years (paralleling obesity + GERD)
ACG 2022 BE surveillance + new tools
ACG 2022 BE surveillance (Shaheen 2022):Screening indication (initial endoscopy):Male + chronic GERD (≥ 5 years) + ≥ 1 risk factor: 50+ y/o / central obesity / smoking / family BE / CaucasianWomen have higher screening thresholds (BE incidence ~ 1/3 that of men), only with multiple risk factorsConfirmed BE surveillance frequency:Non-dysplastic BE: endoscopy every 3-5 years + multi-point biopsy (Seattle protocol: 4-quadrant biopsies every 1-2 cm)Indefinite for dysplasia: repeat endoscopy in 6 monthsLGD: every 6-12 months + consider endoscopic ablationHGD: endoscopic curative treatment (RFA radiofrequency ablation / EMR endoscopic mucosal resection)Long-term PPI: clear indication in BE; benefit > risk; do not stop due to long-term-PPI concerns
New tools:
Chromoendoscopy / NBI: improves LGD/HGD detectionCytosponge (swallowed sponge): screening tool, not widely used in ChinaGenomic testing (TissueCypher and others): stratifies progression risk
Chest pain differential
Chest pain differential — reflux vs angina vs esophageal spasm:Reflux chest pain closely mimics angina — both travel the same visceral afferent pathway (T1-T4) → same cortical region. Never assume "acid regurgitation = GERD."
| Feature | GERD chest pain | Angina | Esophageal spasm |
|---|---|---|---|
| Trigger | Heavy meal / lying down / bending | Exertion / emotion / cold | Cold/hot drinks / swallowing |
| Relief | Antacid / upright / PPI | Rest + nitroglycerin | Self-limited / CCB |
| Quality | Burning / acid | Crushing / tight / breathless | Squeezing / spasm |
| Radiation | Upward to throat | Left shoulder / jaw / left arm | Same as angina (hard to tell apart) |
| Duration | Tens of minutes | 3-15 minutes | Seconds to minutes |
| Sweat / nausea / breathlessness | Rare | Common | Occasional |
| Nocturnal | Common in recumbent posture | Unstable / Prinzmetal | Rare |
| First-line test | PPI trial | ECG + troponin | Esophageal manometry |
Red flags + practice
Red flags (immediate ER / rule out cardiac):40+ y/o + new chest pain + exertion-induced + sweating / breathless / nausea → ER ECG + troponin; do not assume GERDWomen's angina often presents atypically (epigastric burning / back pain / extreme fatigue) → easily misdiagnosed as "a stomach problem"Known cardiovascular history / high risk (smoking + HTN + DM + dyslipidemia + family history) → even if "it feels like reflux," cardiac comes first
Classic Eckardt data: among ER patients with chief complaint of "heartburn," 5-15% are actually cardiac. This is one of GERD teaching's most consequential blind spots.
Practice:
First-episode chest pain + any cardiovascular risk factor: ER ECG + troponin + coronary CTA/angiography if needed; only then GERDEstablished GERD + typical burning + recumbent worsening + antacid relief: clinical GERD, try PPIExertional chest pain: rule out cardiac first, alwaysEsophageal spasm (nutcracker / DES): confirm with manometry; CCB (nifedipine) or nitroglycerin can be tried
Chapter 4
Lifestyle + decision
Lifestyle + decision
Lifestyle interventions (strong evidence) + decision path:
① Weight loss 5-10%:
Single strongest intervention (BMI ≥ 25)↓ abdominal pressure → ↓ refluxJacobson 2006 NEJM: every 5 kg of weight loss → ↓ GERD symptoms
② Head-of-bed elevation 15-20 cm:
Not "more pillows" — elevate the entire head of the bed (wood blocks / wedge cushion)Nocturnal only, not a substitute for daytime dietary control
③ Dinner ≤ 7 PM, no late-night snacking:
Dinner-to-bedtime gap ≥ 3 hours"Eat and go to bed" = GERD behavior #1
④ Small portions + eat slowly:
Large meals → gastric distension → ↑ TLESR
⑤ Avoid trigger foods (individualised):
Keep a food + symptom diary for 2-4 weeks to identify personal triggersCommon triggers: high fat / chocolate / mint / coffee / tea / alcohol / soft drinks / spicy / tomato / citrus
⑥ Quit smoking + limit alcohol:
Smoking → ↓ LES pressure + ↓ saliva productionAlcohol → direct LES relaxation
⑦ Left-lateral sleeping:
Anatomical: reflux is lower in left- than right-side sleeping (effective for some)
⑧ No tight clothing + no bending over after meals
Drug stratification:
Mild (1-2 episodes/week): antacid on demand / H2RA on demandModerate (≥ 3 episodes/week + impacts life): regular H2RA / 4-8-week PPI trialSevere + esophagitis: 8-12 weeks PPI + assessmentRefractory: double-dose PPI / add bedtime H2RA / endoscopic evaluation / P-CAB (vonoprazan) upgrade
Surgery (refractory + esophagitis + years of PPI):
Nissen fundoplication (laparoscopic): reshapes the LESMagnetic sphincter augmentation (LINX device): new, minimally invasiveTIF (Transoral Incisionless Fundoplication): endoscopicSuited to long-term PPI dependence + unwilling to continue + endoscopically severe GERD
Connections to other atlas stories:
vitamin-b12/stomach L4 (low acid and B12 absorption)calcium + magnesium + iron (absorption impact)digestive L3 systemtype-2-diabetes (diabetic gastroparesis)osteoporosis (PPI long-term fracture risk)alcohol-metabolism + UPF + fructose (dietary triggers)
Atlas position:
GERD is common but commonly underestimated / overtreatedPPIs are "powerful but to be used carefully" — not "a casual stomach pill"Lifestyle + lowest-dose PPI with clear indication = the gold standard"Is long-term PPI safe?": in patients with a clear indication, benefit > risk; in unnecessary use, the risk is unjustified
① Weight loss 5-10%:
Single strongest intervention (BMI ≥ 25)↓ abdominal pressure → ↓ refluxJacobson 2006 NEJM: every 5 kg of weight loss → ↓ GERD symptoms
② Head-of-bed elevation 15-20 cm:
Not "more pillows" — elevate the entire head of the bed (wood blocks / wedge cushion)Nocturnal only, not a substitute for daytime dietary control
③ Dinner ≤ 7 PM, no late-night snacking:
Dinner-to-bedtime gap ≥ 3 hours"Eat and go to bed" = GERD behavior #1
④ Small portions + eat slowly:
Large meals → gastric distension → ↑ TLESR
⑤ Avoid trigger foods (individualised):
Keep a food + symptom diary for 2-4 weeks to identify personal triggersCommon triggers: high fat / chocolate / mint / coffee / tea / alcohol / soft drinks / spicy / tomato / citrus
⑥ Quit smoking + limit alcohol:
Smoking → ↓ LES pressure + ↓ saliva productionAlcohol → direct LES relaxation
⑦ Left-lateral sleeping:
Anatomical: reflux is lower in left- than right-side sleeping (effective for some)
⑧ No tight clothing + no bending over after meals
Drug stratification:
Mild (1-2 episodes/week): antacid on demand / H2RA on demandModerate (≥ 3 episodes/week + impacts life): regular H2RA / 4-8-week PPI trialSevere + esophagitis: 8-12 weeks PPI + assessmentRefractory: double-dose PPI / add bedtime H2RA / endoscopic evaluation / P-CAB (vonoprazan) upgrade
Surgery (refractory + esophagitis + years of PPI):
Nissen fundoplication (laparoscopic): reshapes the LESMagnetic sphincter augmentation (LINX device): new, minimally invasiveTIF (Transoral Incisionless Fundoplication): endoscopicSuited to long-term PPI dependence + unwilling to continue + endoscopically severe GERD
Connections to other atlas stories:
vitamin-b12/stomach L4 (low acid and B12 absorption)calcium + magnesium + iron (absorption impact)digestive L3 systemtype-2-diabetes (diabetic gastroparesis)osteoporosis (PPI long-term fracture risk)alcohol-metabolism + UPF + fructose (dietary triggers)
Atlas position:
GERD is common but commonly underestimated / overtreatedPPIs are "powerful but to be used carefully" — not "a casual stomach pill"Lifestyle + lowest-dose PPI with clear indication = the gold standard"Is long-term PPI safe?": in patients with a clear indication, benefit > risk; in unnecessary use, the risk is unjustified
Nocturnal + pregnancy + diary
Nocturnal GERD is the hardest subtype to manage and the one most likely to cause Barrett's / aspiration / asthma / sleep disruption. Written separately.Why nocturnal GERD is severe:
Supine position removes gravity → reflux contents dwell in the esophagus for 30+ minutes (vs < 5 minutes upright)Saliva production drops ~ 50% at night → poor esophageal self-clearanceSwallowing frequency drops at night → refluxate is not propelled backLES tone is physiologically lower at nightREM-associated LES relaxation: TLESR frequency peaks in REM sleepNet result: nocturnal reflux exposure damages the esophagus 2-3× more than the same volume in daytime
Nocturnal GERD 7-piece kit (in order of strength):
1. Dinner ≤ 7 PM + bedtime gap ≥ 3 hours (most important)
2. Entire bed-head elevation 15-20 cm (not pillows) — wedge cushion / wood block under bedposts
3. Left-lateral sleeping — the stomach lies below the esophagus, gravity helps; right-lateral and supine are the worst
4. PPI 30 min before breakfast (maximises nocturnal coverage) + H2RA at bedtime (dual coverage, for refractory cases)
5. Avoid triggers: high-fat dinner / chocolate / alcohol / large fluid intake (right before bed)
6. Weight loss: even 5 kg substantially reduces nocturnal reflux
7. CPAP (if comorbid OSA) — OSA + GERD are mutually causal; treating both doubles the benefit (atlas sleep-apnea island)
Nocturnal-specific tools:
MedCline positional wedge (wedge + side-sleep fixation): moderate clinical evidence, effective in someAdjustable electric bed: long-term investment but most comfortableReza Band (external UES compression): a new option for LPR / microaspiration patients
Pregnancy GERD management (40-80% of pregnant women):
Mechanism:
Rising progesterone → ↓ LES toneEnlarging uterus + ↑ abdominal pressure → worsens refluxUsually starts in the second trimester, resolves after delivery
Safe medications (pregnancy-OK):
Alginate (Gaviscon) — safest, physical barrier, not absorbedCalcium-carbonate antacid (Tums) — safe + incidental calcium, but excess → sodium/calcium overloadMg/Al hydroxide antacid — short-term OK; long-term Mg may cause diarrheaFamotidine (H2RA) — pregnancy Category B, good long-term data, used for moderate-severePPI — mostly Category B (omeprazole has the most data, esomeprazole also B); avoid first trimester, mid-late only after obstetric review
Not recommended in pregnancy:
Cisapride — withdrawnBaking soda (sodium bicarbonate) — sodium overload
Non-pharmacologic in pregnancy:
Small frequent meals (5-6 vs 3 large)Sit 1 hour after dinner before lying downLeft-lateral + head-of-bed elevationAvoid triggers
Food + symptom diary template (2-4 weeks):
```
Date | Meal time | Food items | Portion | 1 h post-meal symptoms (0-10) | Nocturnal symptoms (0-10) | Medications that day
```
Analysis method:
After 4 weeks, look at the foods common to your "high-symptom days" vs "low-symptom days"Do not cut all "theoretical triggers" at once — individual variability is high; some are insensitive to chili but extremely sensitive to chocolateTriggers are often combinations: "8 PM dinner + alcohol + large portion" rather than a single foodFor chronic patients, pick the 3-5 most reliable triggers to avoid long-term, and let the rest return in moderation — don't turn life into a strict regime
Atlas connections:
Nocturnal GERD + insomnia → atlas insomnia L3Nocturnal GERD + OSA → atlas sleep-apnea L3Weight loss + visceral fat → atlas endocrine/metabolic-syndrome L4Pregnancy → atlas reproductive L3